K. Yamaoka et al., ACTIVATION OF STAT5 BY LIPOPOLYSACCHARIDE THROUGH GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR PRODUCTION IN HUMAN MONOCYTES, The Journal of immunology, 160(2), 1998, pp. 838-845
LPS is a potent stimulator of monocytes, inducing many of their functi
ons. Although the details of how LPS exerts such functions remain larg
ely unknown, transcription factors such as nuclear factor-kappa B, nuc
lear factor-IL-6, and activator protein-1 have been shown to be involv
ed in this process. However, to date it has been thought that no known
STAT molecule plays a role in the activation of monocytes by LPS. In
this study we examined whether some known STAT molecule is stimulated
by LPS, based on the finding that a GAS motif sequence is conserved in
the promoter regions of human, mouse, and rat cyclo-oxygenase-2 (COX-
2) genes. Consequently, LPS induced activation of STAT5 in human monoc
ytes, and this STAT5 activation occurred in an indirect way via granul
ocyte-macrophage CSF (CM-CSF) secreted by LPS-stimulated monocytes. Ex
pression of COX-2 protein was partially reduced by treatment of anti-h
uman GM-CSF Ab. Activation of STAT5 was inhibited by either IL-10 or d
examethasone (Dex), but not by aspirin. IL-10 blocked activation of ST
AT5 indirectly by suppressing CM-CSF production, while Dex inhibited t
his activation both directly and indirectly. Taken together, these res
ults suggest that in addition to other transcription factors, STAT5 pl
ays an important role in activation of monocytes by LPS, and that STAT
5 is another target for IL-10 and Dex to inhibit COX-2 expression in a
ctivated monocytes.